Literature DB >> 24971701

Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin.

Rahul D Pawar1, Beatrice Goilav2, Yumin Xia1, Haoyang Zhuang3, Leal Herlitz4, Westley H Reeves3, Chaim Putterman5.   

Abstract

The onset of autoantibodies in systemic autoimmunity can be the result of a breakdown in tolerance at multiple checkpoints. Genetic, hormonal, and immunological factors can combine with environmental influences to accelerate the onset of disease and aggravate disease outcome. Here, we describe a novel mechanism relating to the regulatory role of Neutrophil Gelatinase Associated Lipocalin (NGAL) in modulating the levels of autoantibodies in pristane induced lupus. Following a single injection of pristane intraperitoneally, NGAL expression was induced in both the serum and spleen. Furthermore, NGAL deficient mice were more susceptible to the induction of pristane stimulated autoimmunity, and displayed higher numbers of autoantibody secreting cells and increased expression of activation induced cytidine deaminase (AID) and other inflammatory mediators in the spleen. In contrast, kidney damage was milder in NGAL deficient mice, indicating that NGAL was detrimental in autoantibody mediated kidney disease. These studies indicate that NGAL plays differential roles in different tissues in the context of lupus, and suggest a previously unrecognized role for NGAL in adaptive immunity.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoantibodies; Lipocalin-2; NGAL; Pristane; SLE

Mesh:

Substances:

Year:  2014        PMID: 24971701      PMCID: PMC4119527          DOI: 10.1016/j.clim.2014.06.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  78 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies.

Authors:  Bisram Deocharan; Xiaoping Qing; Juan Lichauco; Chaim Putterman
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

3.  TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.

Authors:  S A Summers; A Hoi; O M Steinmetz; K M O'Sullivan; J D Ooi; D Odobasic; S Akira; A R Kitching; S R Holdsworth
Journal:  J Autoimmun       Date:  2010-12       Impact factor: 7.094

4.  Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis.

Authors:  Tamar Rubinstein; Milena Pitashny; Benjamin Levine; Noa Schwartz; Julie Schwartzman; Elena Weinstein; Jose M Pego-Reigosa; Tim Y-T Lu; David Isenberg; Anisur Rahman; Chaim Putterman
Journal:  Rheumatology (Oxford)       Date:  2010-02-09       Impact factor: 7.580

5.  Tubular lesions and tubular cell adhesion molecules for the prognosis of lupus nephritis.

Authors:  L Daniel; H Sichez; R Giorgi; B Dussol; D Figarella-Branger; J F Pellissier; Y Berland
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

Review 6.  Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse.

Authors:  L Kjeldsen; J B Cowland; N Borregaard
Journal:  Biochim Biophys Acta       Date:  2000-10-18

7.  Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation.

Authors:  L R Devireddy; J G Teodoro; F A Richard; M R Green
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

8.  Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice.

Authors:  Hua-Xin Gao; Elena Sanders; Arlene Tan Tieng; Chaim Putterman
Journal:  J Neuroimmunol       Date:  2010-08-25       Impact factor: 3.478

9.  B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).

Authors:  Lena Schiffer; Philipp Kümpers; Ana M Davalos-Misslitz; Marion Haubitz; Hermann Haller; Hans-Joachim Anders; Torsten Witte; Mario Schiffer
Journal:  Nephrol Dial Transplant       Date:  2009-07-13       Impact factor: 5.992

10.  Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC.

Authors:  S Ishikawa; T Sato; M Abe; S Nagai; N Onai; H Yoneyama; Y Zhang ; T Suzuki; S Hashimoto ; T Shirai; M Lipp; K Matsushima
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  5 in total

Review 1.  Biomarkers for kidney involvement in pediatric lupus.

Authors:  Beatrice Goilav; Chaim Putterman; Tamar B Rubinstein
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

2.  Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.

Authors:  Lara A Aqrawi; Hilde Kanli Galtung; Beate Vestad; Reidun Øvstebø; Bernd Thiede; Shermin Rusthen; Alix Young; Eduarda M Guerreiro; Tor Paaske Utheim; Xiangjun Chen; Øygunn Aass Utheim; Øyvind Palm; Janicke Liaaen Jensen
Journal:  Arthritis Res Ther       Date:  2017-01-25       Impact factor: 5.156

3.  Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.

Authors:  Bancha Satirapoj; Chagriya Kitiyakara; Asada Leelahavanichkul; Yingyos Avihingsanon; Ouppatham Supasyndh
Journal:  BMC Nephrol       Date:  2017-08-04       Impact factor: 2.388

4.  Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.

Authors:  Lara A Aqrawi; Hilde Kanli Galtung; Eduarda M Guerreiro; Reidun Øvstebø; Bernd Thiede; Tor Paaske Utheim; Xiangjun Chen; Øygunn Aass Utheim; Øyvind Palm; Kathrine Skarstein; Janicke Liaaen Jensen
Journal:  Arthritis Res Ther       Date:  2019-07-31       Impact factor: 5.156

Review 5.  Salivary Biomarkers in Patients with Sjögren's Syndrome-A Systematic Review.

Authors:  Ju-Yang Jung; Ji-Won Kim; Hyoun-Ah Kim; Chang-Hee Suh
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.